SWOT Analysis of AstraZeneca

Portfolio Paper 2

Table of Contents
INTRODUCTION...........................................................................................................................1
MAIN BODY...................................................................................................................................1
SWOT analysis of AstraZeneca.............................................................................................1
CONCLUSION................................................................................................................................3
REFERENCES................................................................................................................................4

INTRODUCTION
AstraZeneca is an Anglo-Swedish global biopharmaceutical and research organisation
established in the year 1999 and is headquartered at Cambridge, United Kingdom. The report
will cover a description of the organisation’s strengths, weaknesses, opportunities and threats
with the help of SWOT analysis.
MAIN BODY
AstraZeneca is driven and led by scientific research and innovation in its pharmaceutical
sector that is used by millions of people across the globe. With the help of SWOT analysis the
potential threats and opportunities for organisation are being identified along with its strengths
and weaknesses (Нурмагомедова, М. К. And et. al., 2020).
Source: https://www.educba.com/swot-anal
SWOT analysis of AstraZeneca
SWOT analysis is an effective tool that it is used by organisations to identify their
strengths and weaknesses along with upcoming opportunities as well as threats (Meskauskas and
et. al., 2020). SWOT of AstraZeneca is as follows:
Strengths Weaknesses
1